CRISPR技術市場：製品、用途、エンドユーザー別-2025-2030年の世界予測

CRISPR技術市場は、2023年に32億5,000万米ドルと評価され、2024年には37億7,000万米ドルに達すると予測され、CAGR 16.52％で成長し、2030年には94億9,000万米ドルに達すると予測されています。

遺伝子編集のための画期的なツールであるCRISPR技術は、DNAの正確な改変を可能にすることで、遺伝学とバイオテクノロジーの分野に革命をもたらしました。その応用範囲は、遺伝性疾患の治療用遺伝子編集、作物のゲノム改変による農業の進歩、研究目的の遺伝子改変モデルの開発など、広範囲に及ぶ。アンメットキーワードの必要性は、満たされていない医療ニーズに対応し、農業の生産性を向上させ、科学研究を促進する可能性によってもたらされます。最終用途分野にはヘルスケア、農業、バイオテクノロジー産業が含まれ、それぞれがこの技術を活用して製品の提供やイノベーションを強化しています。

市場成長は、新規治療アプローチを必要とする遺伝性疾患の有病率の増加、食糧安全保障を確保するための農業バイオテクノロジーの進歩、官民両団体による研究開発への多額の投資に影響されています。CRISPRの応用を治療や農業だけでなく、バイオ燃料生産や環境管理などの分野にも拡大することで、潜在的なビジネスチャンスが生まれる可能性があります。こうした機会を活用するために、企業は戦略的パートナーシップや共同研究、精密編集のためのゲノム学におけるAIの俊敏な統合、遺伝子治療のための強固な送達システムの開発に注力すべきです。

しかし、市場は倫理的・安全性への懸念、厳しい規制の枠組み、CRISPR特許に関連する知的財産権の複雑な性質といった課題に直面しています。これらの課題を克服するには、倫理的問題に対処するための包括的な利害関係者の関与、規制の経路を効率的にナビゲートすること、強力な知的財産管理戦略を確立することが必要です。CRISPRの特異性と効率の向上、新規送達メカニズムの開発、あまり研究されていない、あるいは希少な遺伝子疾患への治療応用の検討など、技術革新と調査の機が熟している分野もあります。全体として、市場情勢力学はダイナミックであり、技術革新に牽引され、規制状況を乗り切り、技術的限界を押し広げながら倫理的配慮に効果的に対処できる企業には大きなビジネスチャンスがあります。

市場力学：急速に進化するCRISPR技術市場の主要市場インサイトを公開

CRISPR技術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 遺伝性疾患に対する新しいワクチンや治療に対するニーズの高まり
  • バイオテクノロジーおよび製薬分野への民間および公的投資の増加
• 市場抑制要因
  • 政府規制による高コストと複雑さ
• 市場機会
  • CRISPR技術の進歩と改良
  • 農業分野でのCRISPR技術使用の可能性
• 市場の課題
  • CRISPR技術に関する技術的課題と倫理的懸念

ポーターの5つの力：CRISPR技術市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、CRISPR技術市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：CRISPR技術市場における外部からの影響の把握

外部マクロ環境要因は、CRISPR技術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析CRISPR技術市場における競合情勢の把握

CRISPR技術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスCRISPR技術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、CRISPR技術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 遺伝性疾患に対する新たなワクチンと治療法の必要性が高まる
    • バイオテクノロジーおよび製薬分野への民間および公的投資の増加
  • 抑制要因
    • 政府の規制に伴う高コストと複雑さ
  • 機会
    • CRISPR技術の進歩と改善
    • 農業分野におけるCRISPR技術の潜在的な用途
  • 課題
    • CRISPR技術に関連する技術的な課題と倫理的な懸念
• 市場セグメンテーション分析
  • 提供内容：調査活動の急増と製品の改善により、CRISPRキットと試薬の使用が増加しています。
  • 応用：農業分野におけるCRISPR技術の使用拡大
  • エンドユーザー：バイオテクノロジー企業におけるCRISPR技術の潜在的な応用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ
  • CRISPRはバイオエネルギー生産の実現可能な解決策になりつつある
  • CRISPR技術の特許情勢の拡大

第6章 CRISPR技術市場：提供別

• 製品
  • 酵素
  • ガイドRNA
  • キットと試薬
• サービス
  • 細胞株エンジニアリング
  • gRNA設計とベクター構築
  • スクリーニングサービス

第7章 CRISPR技術市場：用途別

• 農業
• バイオメディカル
• 産業

第8章 CRISPR技術市場：エンドユーザー別

• 学術機関および政府調査機関
• バイオテクノロジー企業
  • 農業企業
  • 製薬会社

第9章 南北アメリカのCRISPR技術市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のCRISPR技術市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのCRISPR技術市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • RoslinCTがCRISPRベースの治療法を開発
  • 初のヒトCRISPR薬が前進
  • ERS Genomics Limited（ERS）がSyngene Internationalとのライセンシング契約を締結
  • Revvity（RVTY）が編集技術へのアクセスを拡大する新サービスを開始
  • ペンシルバイオサイエンス、希少疾患の遺伝子編集の進歩に向け560万ポンドを調達
  • インテグレーテッドDNAテクノロジーズとアルデブロンが戦略的提携を締結し、細胞・遺伝子治療開発者に主要なCRISPRコンポーネントを提供
  • Bedoukian調査Inc.はInscriptaと提携し、天然由来の原料を持続的に開発・製造します。
  • Scribe、生体内CRISPRベースの遺伝子医薬品の開発を加速するための提携を発表
  • Vertex、FDAの決定に先立ち初のCrispr遺伝子編集療法の発売計画を示唆
  • シャーロック・バイオサイエンスがセンス・バイオディテクションを買収
  • インテルリア・セラピューティクス、リライト・セラピューティクスの買収を発表

企業一覧

• Agilent Technologies, Inc.
• Applied StemCell, Inc.
• Beam Therapeutics Inc.
• Caribou Biosciences, Inc.
• Cellectis S.A.
• CRISPR Therapeutics AG
• Danaher Corporation
• Editas Medicine, Inc.
• ERS Genomics Limited
• Function Oncology
• GeneCopoeia, Inc.
• GenScript Biotech Corporation
• Horizon Discovery Group Ltd. by Revvity, Inc.
• Inscripta, Inc.
• Intellia Therapeutics, Inc.
• Lonza Group Ltd.
• Mammoth Biosciences, Inc.
• Merck KGaA
• New England Biolabs, Inc.
• OriGene Technologies, Inc.
• Prime Medicine, Inc.
• Scribe Therapeutics
• Sherlock Biosciences, Inc.
• Synthego Corporation
• Takara Holdings Inc.
• Thermo Fisher Scientific Inc.
• ToolGen, Inc.
• TriLink BioTechnologies by Maravai Intermediate Holdings, LLC
• Twist Bioscience Corporation
• Verve Therapeutics, Inc.

LIST OF FIGURES

• FIGURE 1. CRISPR TECHNOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. CRISPR TECHNOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CRISPR TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CRISPR TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CRISPR TECHNOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CRISPR TECHNOLOGY MARKET DYNAMICS
• TABLE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GUIDE RNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GRNA DESIGN & VECTOR CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 47. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 48. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 79. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 80. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 82. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 85. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 86. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 88. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 115. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 127. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 133. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 139. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 145. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 152. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 158. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 164. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 170. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 176. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 182. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 188. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 189. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 191. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 194. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 200. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 206. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 212. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 213. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 215. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 218. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 219. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 221. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 224. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 230. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 242. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 248. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 254. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 260. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 266. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 272. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
• TABLE 278. CRISPR TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 279. CRISPR TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

The CRISPR Technology Market was valued at USD 3.25 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 16.52%, to USD 9.49 billion by 2030.

CRISPR technology, a groundbreaking tool for gene editing, has revolutionized the fields of genetics and biotechnology by allowing precise modifications to DNA. Its scope encompasses a vast range of applications including therapeutic gene editing for genetic disorders, agricultural advancements through crop genome modification, and the development of genetically engineered models for research purposes. The necessity for CRISPR technology is driven by its potential to address unmet medical needs, improve agricultural productivity, and facilitate scientific research. End-use sectors include healthcare, agriculture, and biotechnology industries, each leveraging the technology to enhance product offerings and innovations.

Market growth is influenced by the increasing prevalence of genetic disorders that necessitate novel therapeutic approaches, advancements in agricultural biotechnology to ensure food security, and substantial investments in R&D from both public and private entities. Potential opportunities lie in expanding CRISPR applications beyond therapeutics and agriculture into areas like biofuel production and environmental management. To capitalize on these opportunities, companies should focus on strategic partnerships and collaborations, agile integration of AI in genomics for precision editing, and development of robust delivery systems for gene therapies.

However, the market faces challenges such as ethical and safety concerns, stringent regulatory frameworks, and the complex nature of intellectual property rights pertaining to CRISPR patents. Overcoming these challenges requires comprehensive stakeholder engagement to address ethical issues, navigating regulatory pathways efficiently, and establishing strong IP management strategies. Areas of innovation and research ripe for exploration include enhancing CRISPR specificity and efficiency, developing novel delivery mechanisms, and exploring therapeutic applications in less-studied or rare genetic conditions. Overall, the CRISPR technology market is dynamic, driven by innovation, with substantial opportunities for businesses that can navigate the regulatory landscape and address ethical considerations effectively while pushing forward technological boundaries.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CRISPR Technology Market

The CRISPR Technology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing need for new vaccines and treatments for genetic diseases
  • Increasing private and public investments in biotechnological and pharmaceutical sectors
• Market Restraints
  • High cost and complexities involved in the government regulations
• Market Opportunities
  • Advancements and improvements in CRISPR technology
  • Potential use of CRISPR technology in the agriculture sector
• Market Challenges
  • Technical challenges and ethical concerns associated with CRISPR technology

Porter's Five Forces: A Strategic Tool for Navigating the CRISPR Technology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CRISPR Technology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CRISPR Technology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CRISPR Technology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CRISPR Technology Market

A detailed market share analysis in the CRISPR Technology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CRISPR Technology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CRISPR Technology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Technology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied StemCell, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., ERS Genomics Limited, Function Oncology, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Scribe Therapeutics, Sherlock Biosciences, Inc., Synthego Corporation, Takara Holdings Inc., Thermo Fisher Scientific Inc., ToolGen, Inc., TriLink BioTechnologies by Maravai Intermediate Holdings, LLC, Twist Bioscience Corporation, and Verve Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Product and Services. The Product is further studied across Enzymes, Guide RNA, and Kits & Reagents. The Services is further studied across Cell Line Engineering, gRNA Design & Vector Construction, and Screening Services.
• Based on Application, market is studied across Agricultural, Biomedical, and Industrial.
• Based on End User, market is studied across Academics & Government Research Institutes and Biotechnology Companies. The Biotechnology Companies is further studied across Agricultural Companies and Pharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Georgia, Illinois, Kentucky, Michigan, Mississippi, New Jersey, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
    • 5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and complexities involved in the government regulations
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements and improvements in CRISPR technology
    • 5.1.3.2. Potential use of CRISPR technology in the agriculture sector
  • 5.1.4. Challenges
    • 5.1.4.1. Technical challenges and ethical concerns associated with CRISPR technology
• 5.2. Market Segmentation Analysis
  • 5.2.1. Offering: Increasing use of CRISPR kits & reagents with the surging research activities and product improvements
  • 5.2.2. Application: Proliferating use of CRISPR technology in the agricultural sector
  • 5.2.3. End-User: Potential application of CRISPR technology in biotechnology companies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization
  • 5.5.1. CRISPR becoming a viable solution for bioenergy production
  • 5.5.2. Expanding patent landscape for CRISPR technology

6. CRISPR Technology Market, by Offering

• 6.1. Introduction
• 6.2. Product
  • 6.2.1. Enzymes
  • 6.2.2. Guide RNA
  • 6.2.3. Kits & Reagents
• 6.3. Services
  • 6.3.1. Cell Line Engineering
  • 6.3.2. gRNA Design & Vector Construction
  • 6.3.3. Screening Services

7. CRISPR Technology Market, by Application

• 7.1. Introduction
• 7.2. Agricultural
• 7.3. Biomedical
• 7.4. Industrial

8. CRISPR Technology Market, by End User

• 8.1. Introduction
• 8.2. Academics & Government Research Institutes
• 8.3. Biotechnology Companies
  • 8.3.1. Agricultural Companies
  • 8.3.2. Pharmaceutical Companies

9. Americas CRISPR Technology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific CRISPR Technology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa CRISPR Technology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. RoslinCT Manufacture CRISPR-Based Therapy
  • 12.3.2. First Human CRISPR Drug Moves Forward
  • 12.3.3. ERS Genomics Limited ('ERS') Completes Licensing Agreement With Syngene International
  • 12.3.4. Revvity's (RVTY) New Launch to Widen Access to Editing Technology
  • 12.3.5. Pencil Biosciences Raises GBP 5.6 Million to Advance Gene Editing for Rare Diseases
  • 12.3.6. Integrated DNA Technologies and Aldevron Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers
  • 12.3.7. Bedoukian Research Inc. Partners with Inscripta to Sustainably Develop and Manufacture Naturally Produced Ingredients
  • 12.3.8. Scribe Announces Collaboration to Accelerate In Vivo CRISPR-Based Genetic Medicines
  • 12.3.9. Vertex Teases Launch Plans for First Crispr Gene Editing Therapy Ahead of FDA Decision
  • 12.3.10. Sherlock Biosciences to Acquire Sense Biodetection
  • 12.3.11. Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Applied StemCell, Inc.
• 3. Beam Therapeutics Inc.
• 4. Caribou Biosciences, Inc.
• 5. Cellectis S.A.
• 6. CRISPR Therapeutics AG
• 7. Danaher Corporation
• 8. Editas Medicine, Inc.
• 9. ERS Genomics Limited
• 10. Function Oncology
• 11. GeneCopoeia, Inc.
• 12. GenScript Biotech Corporation
• 13. Horizon Discovery Group Ltd. by Revvity, Inc.
• 14. Inscripta, Inc.
• 15. Intellia Therapeutics, Inc.
• 16. Lonza Group Ltd.
• 17. Mammoth Biosciences, Inc.
• 18. Merck KGaA
• 19. New England Biolabs, Inc.
• 20. OriGene Technologies, Inc.
• 21. Prime Medicine, Inc.
• 22. Scribe Therapeutics
• 23. Sherlock Biosciences, Inc.
• 24. Synthego Corporation
• 25. Takara Holdings Inc.
• 26. Thermo Fisher Scientific Inc.
• 27. ToolGen, Inc.
• 28. TriLink BioTechnologies by Maravai Intermediate Holdings, LLC
• 29. Twist Bioscience Corporation
• 30. Verve Therapeutics, Inc.